MacroGenics to Participate in the Stifel 2025 Healthcare Conference
MacroGenics (Nasdaq: MGNX) announced that President and CEO Eric Risser will participate in a fireside chat at the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025 at 4:00 PM ET in New York.
A live webcast will be available via the company's Investor Relations "Events & Presentations" page and an archived replay will be maintained on the website for 30 days.
MacroGenics (Nasdaq: MGNX) ha annunciato che il presidente e CEO Eric Risser parteciperà a un fireside chat al Stifel 2025 Healthcare Conference giovedì 13 novembre 2025 alle 16:00 ET a New York.
Una trasmissione webcast in diretta sarà disponibile tramite la pagina delle Relazioni con gli Investitori "Events & Presentations" e una replica archiviata sarà disponibile sul sito per 30 days.
MacroGenics (Nasdaq: MGNX) anunció que el presidente y director ejecutivo Eric Risser participará en una charla informal (fireside chat) en la Stifel 2025 Healthcare Conference el jueves 13 de noviembre de 2025 a las 4:00 PM ET en Nueva York.
Una transmisión en directo estará disponible a través de la página de Relaciones con Inversores "Events & Presentations" y se mantendrá una reproducción grabada en el sitio web durante 30 days.
MacroGenics (Nasdaq: MGNX)가 발표했습니다. 회장 겸 CEO Eric Risser가 Stifel 2025 Healthcare Conference에서 fireside chat에 참여할 예정이며, 일정은 2025년 11월 13일 목요일 ET 오후 4:00에 뉴욕에서 진행됩니다.
라이브 웹캐스트는 회사의 투자자 관계 페이지의 "Events & Presentations" 섹션에서 이용 가능하며, 아카이브 재생은 웹사이트에 30 days 동안 보존됩니다.
MacroGenics (Nasdaq: MGNX) a annoncé que le président et PDG Eric Risser participera à une fireside chat lors de la Stifel 2025 Healthcare Conference le jeudi 13 novembre 2025 à 16h00 ET à New York.
Une retransmission en direct sera disponible via la page des Relations Investisseurs "Events & Presentations" et une rediffusion sera conservée sur le site pendant 30 days.
MacroGenics (Nasdaq: MGNX) gab bekannt, dass der Präsident und CEO Eric Risser an einem Fireside-Chat bei der Stifel 2025 Healthcare Conference am Donnerstag, 13. November 2025, um 16:00 Uhr ET in New York teilnehmen wird.
Ein Live-Webcast wird über die Seite Investor Relations "Events & Presentations" des Unternehmens verfügbar sein, und eine archivierte Wiederholung wird auf der Website für 30 days bereitgehalten.
أعلنت MacroGenics (نازدك: MGNX) أن الرئيس التنفيذي ورئيس مجلس الإدارة Eric Risser سيشارك في دردشة fireside خلال Stifel 2025 Healthcare Conference يوم الخميس 13 نوفمبر 2025 في تمام الساعة 4:00 مساءً بتوقيت شرق الولايات المتحدة في نيويورك.
سيكون البث المباشر عبر صفحة علاقات المستثمرين للشركة "Events & Presentations"، وسيتم الاحتفاظ بإعادة عرض أرشيفية على الموقع لمدة 30 days.
- None.
- None.
ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025, at 4:00 pm ET in New York, NY.
A webcast of the presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain an archived replay of the webcast on its website for 30 days.
About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

Contacts: Jim Karrels, Senior Vice President, CFO 1-301-251-5172 info@macrogenics.com Argot Partners 1-212-600-1902 macrogenics@argotpartners.com